Eisai’s Leqembi Launch Bodes Well For Biogen In A Pivotal Year

 
• By Mandy Jackson

Eisai said the US launch of Alzheimer’s therapy Leqembi following accelerated approval is going well, which is welcome news for partner Biogen as it brings on a new CEO and recovers from a failed Aduhelm launch.  

hand shows a rocket and an icon
Eisai seems to have the Leqembi launch well in hand, so far • Source: Shutterstock

More from New Products

More from Scrip